Connect with us
Agomab raised $90 million in Series D funding, led by Asabys, Sanofi, and Invus. Funds will advance clinical trials for its lead fibrosis treatments, including Agmb-129...
Asabys, which counts Alantra as a strategic partner, launched the first fund four years ago with an initial target of €60 million and the support of...
The company Inbrain Neuroelectronics, which emerged from the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and Icrea, closes a $16.85 million (€14.3 million) round led by...
Spanish investment funds and venture capital managers have avoided the impact of the pandemic and have continued to invest in the health sector. Spanish biotech companies...